Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 238 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2450 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-01 | 2023-02-09 | 176854 |
TEVA-DOXAZOSIN | 1MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176857 |
AERMONY RESPICLICK | 232MCG | POWDER (METERED DOSE) | Resolved | 2022-12-01 | 2023-04-28 | 176860 |
PORTIA 21 | 0.03MG 0.15MG | TABLET | Resolved | 2022-12-08 | 2022-12-22 | 177502 |
PORTIA 28 | 0.03MG 0.15MG | TABLET | Resolved | 2022-12-08 | 2022-12-22 | 177505 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177508 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177511 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-12-08 | 2023-02-02 | 177514 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177517 |
TEVA-CLONIDINE | 0.025MG | TABLET | Resolved | 2022-12-08 | 2023-01-26 | 177520 |
TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2022-12-08 | 2023-04-28 | 177523 |
TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2022-12-08 | 2023-06-09 | 177526 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2022-12-08 | 2023-01-19 | 177529 |
TEVA-ZOPICLONE | 7.5MG | TABLET | Resolved | 2022-12-08 | 2022-12-15 | 177532 |
ZADITEN | 1MG | TABLET | Resolved | 2022-12-08 | 2023-04-15 | 177535 |
ACT AMLODIPINE | 5MG | TABLET | Resolved | 2022-12-15 | 2023-02-16 | 178518 |
ACT LEVOFLOXACIN | 250MG | TABLET | Resolved | 2022-12-15 | 2023-04-28 | 178521 |
TEVA-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-12-15 | 2023-10-04 | 178524 |
TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-12-15 | 2023-06-09 | 178527 |
TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2022-12-15 | 2023-07-06 | 178530 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |